Home » Nonselective NSAIDs Slated for Further EMEA Scrutiny
Nonselective NSAIDs Slated for Further EMEA Scrutiny
October 16, 2006
In light of continuing concerns about the increased potential for heart attacks and strokes associated with long-term use of certain nonselective nonsteroidal anti-inflammatory drugs (NSAIDs), the European Medicines Agencys (EMEA) Committee for Medicinal Products for Human Use (CHMP) has undertaken a formal review of clinical and epidemiological studies of NSAIDs and plans to make recommendations on how to address those concerns.
To View This Article:
Subscribe To International Pharmaceutical Regulatory Monitor